7 Biotech Stocks Wall Street Says Will Double or More
Kiplinger -

Bull market or bear market, one fact remains unwavering: Biotech stocks represent the ultimate risk/reward plays.

These investments are inherently volatile in nature. Numerous biotechnology companies have just one or two products delivering revenue, which means any news around new potential treatments has added urgency. That results in bigger price swings. "Pre-revenue" biotech stocks - those with no approved products - are even shakier in nature. These companies are in a race to get a...

Read this story at


Related Articles